![]() | Up a level |
(2024) Asthma and chronic obstructive pulmonary disease (COPD) in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 11. ISSN 2211-0348
(2024) Ginger for Pain Management in Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. Journal of Integrative and Complementary Medicine. p. 15. ISSN 2768-3605
(2024) Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19. BMC Infectious Diseases. ISSN 14712334 (ISSN)
(2024) Targeting the Receptor Complexes by Structure-based Natural Drug Compounds in Seizures: A New Dimension in Drug Discovery and Design. Natural Products Journal. p. 21. ISSN 2210-3155
(2024) Which surrogate insulin resistance indices best predict coronary artery disease? A machine learning approach. Cardiovascular Diabetology. ISSN 14752840 (ISSN)
(2023) Addressing conflicts of interest regarding the vaccine in infectious disease outbreaks based on good governance for health approach: a policy brief. BMC Health Services Research. p. 12.
(2022) Cystic Echinococcosis in Central Iran: G1 and G6 Genotypes in Patients. Surgical infections. pp. 451-457.
(2022) Is Celiac Disease (CD) Prevalent in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis. Multiple Sclerosis International. p. 7. ISSN 2090-2654
(2022) Possible Therapeutic Targets from Derivatives of Natural Marine Products Based on PI3K/AKT Dependent Inhibitors in Viral Infection COVID-19. Cellular Physiology and Biochemistry. pp. 707-729. ISSN 1015-8987
(2021) The prevalence of Myocardial Infarction among Multiple Sclerosis Patients: a Systematic Review and Meta-analysis. Multiple Sclerosis and Related Disorders.